医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ResolutionMD® Medical Imaging Software First to Receive Certification for Web and Mobile Diagnosis in Korea

2015年07月29日 PM09:30
このエントリーをはてなブックマークに追加


 

CALGARY, Alberta

Calgary Scientific Inc., a company known for creating innovative technology for the medical industry and beyond, announced today that ResolutionMD® enterprise image-viewer is the first to receive certification from the Ministry of Food and Drug Safety (MFDS) in Korea for diagnosis using both web and mobile devices. This certification enables medical practitioners in Korea to provide a higher standard of care by getting quick, secure mobile access to images from a range of image storage systems using ResolutionMD® with their web, iOS or Android devices. Medical staff can feel confident using a tool certified by the governing agency in Korea.

Obtaining certification from the MFDS means that ResolutionMD®, the world’s leading enterprise image-viewing solution can now be sold and used in Korea. The certification process was lengthy, involving an on-site audit and product and manufacturer quality evaluations. The certificate follows ResolutionMD’s FDA Class II clearance in the US, CFDA certification in China, PDMA certification in Japan, MDCO certification in Hong Kong, CE marking in Europe, TGA certificate in Australia and Health Canada license.

“Obtaining this MFDS certificate in Korea is another significant milestone for Calgary Scientific,” said Pierre Lemire, CTO and EVP, Products at Calgary Scientific. “We are seeing great demand for ResolutionMD® throughout Asia as the adoption of mobile devices continues to grow at a significant pace. I am very pleased that healthcare providers in Korea can now leverage our fully accredited web and mobile solution to get faster image access resulting in better patient care.”

For more information on accreditations, visit www.calgaryscientific.com/accreditation.

About ResolutionMD®

ResolutionMD enables doctors to securely view patient images and reports from a wide variety of computers and mobile devices, collaborate with other practitioners and diagnose from any location. Whether you are a single facility or a large healthcare system with tens of thousands of users, ResolutionMD® is the best choice for seamless image access across multiple departments. The CFDA registered, FDA cleared, Health Canada licensed, CE marked, TGA, PMDA, MDCO and now MFDS certified mobile medical diagnosis software can be integrated into any EMR and easily plugs into existing distributed storage systems. ResolutionMD’s federated approach is an important differentiator from other solutions as highly sensitive data is never moved to an end device and additional data storage locations are not created. ResolutionMD is currently installed in leading healthcare institutions around the world via a network of more than forty-five world class healthcare partners. For more information on ResolutionMD, go to http://www.calgaryscientific.com/resolutionmd.

About Calgary Scientific Inc.

Calgary Scientific is the global leader in web and mobile diagnostic medical imaging and cloud enabling solutions. For more information on Calgary Scientific, go to www.calgaryscientific.com.

© 2015 Calgary Scientific Inc., ResolutionMD, PureWeb and the Calgary Scientific logo are trademarks and/or registered trademarks of Calgary Scientific Inc. or its subsidiaries. Any third-party company names and products are for identification purposes only and may be trademarks of their respective owners.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150729005363/en/

CONTACT

Calgary Scientific Inc.
Jennifer Sobotka, (+1) 403-767-7941
Director
of Marketing
Jennifer.Sobotka@calgaryscientific.com
or
Investor
contact:
Byron Osing, (+1) 403-767-7959
CEO and Chair
Byron.Osing@calgaryscientific.com

同じカテゴリーの記事 

  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024
  • Kolmar Korea Wins Case Against Italian Cosmetics Maker Intercos for Suncare Technology Theft
  • 大手CDMOのPCIファーマ・サービシズが初の包括ESG報告書を発表